Fig. 4From: The effect of treatment with pimobendan in dogs with preclinical mitral valve disease – a placebo-controlled double-blinded crossover studyPost-exercise increase in NT-proBNP under pimobendan treatment. The post-exercise NT-proBNP values increased significantly at baseline examination (p = 0.0203) and at day 90 (p = 0.0058) under pimobendan treatmentBack to article page